Serum cross-linked carboxyterminal telopeptide of type I collagen (ICTP) as a prognostic tumor marker in patients with esophageal squamous cell carcinoma

Cancer

Volumn 94, Issue 4, 2002, Pages 940-949

  Nabeya, Yoshihiro ^a   Shimada, Hideaki ^a   Okazumi, Shinichi ^a   Matsubara, Hisahiro ^a   Gunji, Yoshio ^a   Suzuki, Takao ^a   Ochiai, Takenori ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

(ICTP); Cutoff value; Esophageal carcinoma; Prognosis; Serum cross linked carboxyterminal telopeptide of Type I collagen; Squamous cell carcinoma; Tumor marker; Type I collagen

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; COLLAGEN TYPE 1; CROSSLINKED CARBOXY TERMINAL TELOPEPTIDE OF COLLAGEN TYPE 1; CYTOKERATIN 19 FRAGMENT; PEPTIDE DERIVATIVE; SQUAMOUS CELL CARCINOMA ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COLLAGEN TYPE I; CROSS-LINKING REAGENTS; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PEPTIDE FRAGMENTS; PROCOLLAGEN; PROGNOSIS; PROSPECTIVE STUDIES; RADIOIMMUNOASSAY; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0037083673     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10267     Document Type: Article

References (35)

1. Tumor invasion and metastases-role of the extracellular matrix: Rhoads Memorial Award lecture
2. Basement membrane and the invasive activity of metastatic tumor cells
3. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: A new serum marker of bone collagen degradation
4. Analysing connective tissue metabolites in human serum. Biochemical, physiological and methodological aspects
5. Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen
6. Collagen family of proteins
7. Type I collagen metabolites as tumor markers in patients with lung carcinoma
8. Serum type I collagen degradation markers, ICTP and CrossLaps, are factors for poor survival in lung cancer
9. Type I and III collagen metabolites as predictors of clinical outcome in epithelial ovarian cancer
10. Metastatic potential correlates with enzymatic degradation of basement membrane collagen
11. Serum concentrations of type I collagen carboxyterminal telopeptide (ICTP) and type I procollagen carboxy- and aminoterminal propeptides (PICP, PINP) as markers of metastatic bone disease in breast cancer
12. Bone metabolic markers in bone metastasis of breast cancer
13. Biochemical markers of bone turnover in breast cancer patients with bone metastases: A preliminary report
14. Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma
15. Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer
16. Use of bone turnover marker, pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP), in the assessment and monitoring of bone metastasis in prostate cancer
17. Usefulness of bone metabolic markers in the diagnosis and followup of bone metastasis from lung cancer
18. Usefulness of serum carboxy-terminal telopeptide of type I collagen (ICTP) as a marker of bone metastasis from lung cancer
19. Elevated serum ICTP concentrations reflect poor prognosis in patients with ovarian carcinoma
20. Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma
21. Prognostic value of serum markers of bone metabolism in untreated multiple myeloma patients
22. Diagnosis and treatment of esophageal neoplasms
23. CYFRA 21-1 is a useful marker for esophageal squamous cell carcinoma
24. CYFRA 21-1 as a tumor marker for squamous cell carcinoma of the esophagus
25. Radioimmunoassay for the pyridinoline cross-linked carboxy- terminal telopeptide of type 1 collagen (ICTP): Some basic aspects of the RIA kit and clinical evaluation in various bone disease
26. Measurement of blood concentration of cross-linked carboxyterminal telopeptide of type I collagen (ICTP)
27. Small ultrasonic probes for determination of the depth of superficial esophageal cancer
28. Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma
29. Radioimmunoassay of ICTP (cross-linked carboxyterminal telopeptide of type I collagen) in serum
30. Detection of serum p53 antibodies in patients with esophageal squamous cell carcinoma: Correlation with clinicopathologic features and tumor markers
31. Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma
32. Clinical significance of serum levels of SCC antigen in patients with esophageal squamous cell carcinoma
33. Preoperative high type I collagen degradation marker ICTP reflects advanced breast cancer
34. Reduced concentration of collagen reducible cross links in human trabecular bone with respect to age and osteoporosis